Simon N.r. Harford - 11 Oct 2021 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
CFO and Treasurer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Oct 2021
Net transactions value
-$2,812
Form type
4
Filing time
12 Oct 2021, 16:01:48 UTC
Previous filing
15 Jul 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $2,812 -93 -0.73% $30.23 12,614 11 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 5,864 shares of common stock and 6,750 restricted stock units.